ASX Announcement
Investor Presentation
Investor Presentation
Successful Completion of Dosing in First Patient Cohort
Renowned biotech entrepreneur Paul Hopper on raising money, picking biotech winners and his latest ASX venture
Chimeric’s new very experienced COO has bold vision to move CAR T cell therapy forward
Cancer-free after 12 years: Why you’re hearing the C-word more often
Dr Eliot Bourk, Former Kite Pharma Senior Executive, Joins Chimeric as VP Business & Corporate Development
Chimeric Makes Strong Listing on ASX
Tony Locantro of Alto Capital adds Chimeric Therapeutics to his top stocks list
January 2021 newsletter
Former Juno Executive Cindy Elkins Joins Chimeric Board